These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 581272)

  • 1. Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia.
    Skullerud K; Halvorsen K
    Cancer; 1978 Sep; 42(3):1211-5. PubMed ID: 581272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.
    Rubinstein LJ; Herman MM; Long TF; Wilbur JR
    Cancer; 1975 Feb; 35(2):291-305. PubMed ID: 1053934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity due to CNS therapy for leukemia.
    Pochedly C
    Med Pediatr Oncol; 1977; 3(1):101-15. PubMed ID: 840159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute encephalomyelitis complicated with severe neurological sequelae after intrathecal administration of methotrexate in a patient with acute lymphoblastic leukemia].
    Nishikawa T; Okamoto Y; Maruyama S; Tanabe T; Kurauchi K; Kodama Y; Nakagawa S; Shinkoda Y; Kawano Y
    Rinsho Ketsueki; 2014 Nov; 55(11):2306-10. PubMed ID: 25501412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal methotrexate versus central nervous system leukemia.
    Bleyer WA
    Cancer Drug Deliv; 1984; 1(2):157-67. PubMed ID: 6399986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic treatment of meningeal leukemia in children by intrathecal methotrexate.
    Wahidijat I; Markum AH; Abdulsalam M; Muslichan S; Odang O
    Acta Haematol; 1972; 47(2):81-8. PubMed ID: 4623363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
    Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
    Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
    Winick NJ; Bowman WP; Kamen BA; Roach ES; Rollins N; Jacaruso D; Buchanan GR
    J Natl Cancer Inst; 1992 Feb; 84(4):252-6. PubMed ID: 1734087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-related nonnecrotizing multifocal axonopathy detected by beta-amyloid precursor protein immunohistochemistry.
    Moore BE; Somers NP; Smith TW
    Arch Pathol Lab Med; 2002 Jan; 126(1):79-81. PubMed ID: 11800653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial Hemorrhage Following Intrathecal Methotrexate Therapy for Acute Lymphoblastic Leukaemia.
    Purkait R; Dolai TK; Lath C; Das B
    Indian Pediatr; 2016 May; 53(5):423-4. PubMed ID: 27254055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain damage after intrathecal methotrexate.
    Smith B
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):810-5. PubMed ID: 1058923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of prophylactic treatment of central nervous system leukemia in children. Analysis of CNS prophylactic treatment with cyclic high dose multichemotherapy, craniospinal irradiation, and high dose infusion of MTX].
    Abe Y; Asakura A; Endo N
    Gan To Kagaku Ryoho; 1982 May; 9(5):855-65. PubMed ID: 6964040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate-Induced Neurotoxicity in Hispanic Adolescents with High-Risk Acute Leukemia-A Case Series.
    Giordano L; Akinyede O; Bhatt N; Dighe D; Iqbal A
    J Adolesc Young Adult Oncol; 2017 Sep; 6(3):494-498. PubMed ID: 28338384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity following concurrent intrathecal and moderate-dose intravenous methotrexate.
    Blatt J; Howrie DL; Wollman MR; Phebus C; Mirro J
    Leukemia; 1993 Nov; 7(11):1734-7. PubMed ID: 8231243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive therapy of central nervous system leukemia in children: results of CNS-prophylaxis with intrathecal methotrexate and hydrocortisone (author's transl)].
    Fujimoto T; Goya N; Hiyoshi Y; Yokoyama T; Ito M
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):183-9. PubMed ID: 578065
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the intermittent prophylactic treatment of the central nervous system in adults with acute leukemia.
    Kawamura S; Mikami T; Iwamura H; Sawada Y; Yamaya T; Haneda Y; Sakata Y; Chiba Y; Yoshida Y
    Biomed Pharmacother; 1987; 41(9-10):462-7. PubMed ID: 3482982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.